A distinctive DNA methylation pattern in insufficient sleep.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 02 2019
Historique:
received: 03 09 2018
accepted: 17 12 2018
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 20 8 2020
Statut: epublish

Résumé

Short sleep duration or insomnia may lead to an increased risk of various psychiatric and cardio-metabolic conditions. Since DNA methylation plays a critical role in the regulation of gene expression, studies of differentially methylated positions (DMPs) might be valuable for understanding the mechanisms underlying insomnia. We performed a cross-sectional genome-wide analysis of DNA methylation in relation to self-reported insufficient sleep in individuals from a community-based sample (79 men, aged 39.3 ± 7.3), and in relation to shift work disorder in an occupational cohort (26 men, aged 44.9 ± 9.0). The analysis of DNA methylation data revealed that genes corresponding to selected DMPs form a distinctive pathway: "Nervous System Development" (FDR P value < 0.05). We found that 78% of the DMPs were hypomethylated in cases in both cohorts, suggesting that insufficient sleep may be associated with loss of DNA methylation. A karyoplot revealed clusters of DMPs at various chromosomal regions, including 12 DMPs on chromosome 17, previously associated with Smith-Magenis syndrome, a rare condition comprising disturbed sleep and inverse circadian rhythm. Our findings give novel insights into the DNA methylation patterns associated with sleep loss, possibly modifying processes related to neuroplasticity and neurodegeneration. Future prospective studies are needed to confirm the observed associations.

Identifiants

pubmed: 30718923
doi: 10.1038/s41598-018-38009-0
pii: 10.1038/s41598-018-38009-0
pmc: PMC6362278
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1193

Références

BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
PLoS Genet. 2010 Sep 09;6(9):e1001113
pubmed: 20844574
Am J Med Genet A. 2014 Mar;164A(3):748-52
pubmed: 24357149
Clin Genet. 2007 Jul;72(1):47-58
pubmed: 17594399
Sleep Med. 2014 Feb;15(2):173-9
pubmed: 24382513
Sleep. 2017 Jan 01;40(1):
pubmed: 28364478
Vis Neurosci. 2001 Sep-Oct;18(5):781-7
pubmed: 11925013
Am J Physiol Renal Physiol. 2009 Aug;297(2):F440-50
pubmed: 19458124
Mol Cell Biol. 2012 Oct;32(19):3963-77
pubmed: 22851694
J Sleep Res. 2015 Apr;24(2):124-30
pubmed: 25223586
Genomics. 1999 May 1;57(3):446-50
pubmed: 10329014
Int J Neuropsychopharmacol. 2008 Dec;11(8):1073-84
pubmed: 18593506
Future Oncol. 2014 Dec;10(16):2659-74
pubmed: 25531051
Mol Psychiatry. 2017 Dec;22(12):1680-1690
pubmed: 29086770
PLoS Genet. 2016 Aug 05;12(8):e1006125
pubmed: 27494321
J Neurosci. 2015 Feb 4;35(5):1892-904
pubmed: 25653350
Genes Brain Behav. 2008 Mar;7(2):224-34
pubmed: 17680805
Sleep. 1983;6(3):179-85
pubmed: 6684786
Sleep. 2014 Jan 01;37(1):195-8
pubmed: 24470708
Nat Commun. 2019 Mar 7;10(1):1100
pubmed: 30846698
Sci Rep. 2016 Apr 22;6:24828
pubmed: 27102866
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Sleep. 2009 Apr;32(4):558-65
pubmed: 19413151
Epilepsy Behav. 2013 May;27(2):378-84
pubmed: 23542896
Brain Res. 2000 Dec 8;885(2):303-21
pubmed: 11102586
Carcinogenesis. 2012 Sep;33(9):1754-61
pubmed: 22764135
PLoS One. 2013;8(1):e55306
pubmed: 23372847
Maturitas. 2016 Dec;94:77-83
pubmed: 27823749
Clin Genet. 2007 Jun;71(6):540-50
pubmed: 17539903
PLoS One. 2017 Jul 24;12(7):e0181978
pubmed: 28738082
J Sleep Res. 2016 Dec;25(6):690-701
pubmed: 27126917
PLoS One. 2012;7(4):e33981
pubmed: 22485153
Neuron. 2017 Apr 5;94(1):19-36
pubmed: 28384471
Sleep Med. 2011 Mar;12(3):215-21
pubmed: 21317033
Lipids Health Dis. 2016 Aug 26;15(1):137
pubmed: 27562731
Sleep Med Rev. 1998 May;2(2):117-28
pubmed: 15310506
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):E682-91
pubmed: 24449876
J Sleep Res. 2016 Aug;25(4):454-7
pubmed: 26868677
J Neurosci. 2012 Aug 29;32(35):12192-203
pubmed: 22933801
Am J Med Genet. 1996 Mar 29;62(3):247-54
pubmed: 8882782
Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1588-96
pubmed: 20237303
J Pediatr. 2001 Jul;139(1):111-6
pubmed: 11445803
Chronobiol Int. 2015 Feb;32(1):103-12
pubmed: 25187986
Neuron. 2004 Jan 8;41(1):35-43
pubmed: 14715133
Am J Hum Genet. 2012 Jun 8;90(6):941-9
pubmed: 22578325
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Genome Biol. 2012 Jun 15;13(6):R44
pubmed: 22703947
Physiol Genomics. 2007 Oct 22;31(2):273-80
pubmed: 17666524
Acta Physiol (Oxf). 2013 Aug;208(4):311-28
pubmed: 23746394
Transl Psychiatry. 2014 Jan 21;4:e347
pubmed: 24448209
J Clin Endocrinol Metab. 2015 Sep;100(9):E1255-61
pubmed: 26168277

Auteurs

Alexandra Lahtinen (A)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland. alexandra.lahtinen@helsinki.fi.
Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, PO Box 590, FIN-00029, HUS, Helsinki, Finland. alexandra.lahtinen@helsinki.fi.

Sampsa Puttonen (S)

Work Ability and Working Career, Finnish Institute of Occupational Health, PO Box 40, FI-00032, Työterveyslaitos, Helsinki, Finland.

Päivi Vanttola (P)

Work Ability and Working Career, Finnish Institute of Occupational Health, PO Box 40, FI-00032, Työterveyslaitos, Helsinki, Finland.

Katriina Viitasalo (K)

Finnair Health Services, HEL-IF/67, FI-01053, Finnair, Finland.

Sonja Sulkava (S)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland.
Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, PO Box 590, FIN-00029, HUS, Helsinki, Finland.

Natalia Pervjakova (N)

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 51010, Estonia.

Anni Joensuu (A)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland.
Diabetes and Obesity Research Program, University of Helsinki, PO Box 63, FI-00014, Helsinki, Finland.

Perttu Salo (P)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland.

Auli Toivola (A)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland.

Mikko Härmä (M)

Work Ability and Working Career, Finnish Institute of Occupational Health, PO Box 40, FI-00032, Työterveyslaitos, Helsinki, Finland.

Lili Milani (L)

Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, 51010, Estonia.

Markus Perola (M)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland.
Diabetes and Obesity Research Program, University of Helsinki, PO Box 63, FI-00014, Helsinki, Finland.

Tiina Paunio (T)

Department of Public Health Solutions, Genomics and Biomarkers Unit, National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland. tiina.paunio@helsinki.fi.
Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, PO Box 590, FIN-00029, HUS, Helsinki, Finland. tiina.paunio@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH